1. 1143PResponses and durability of clinical benefit in pancreatic ductal adenocarcinoma (PDAC) patients treated with pegilodecakin (AM0010) in combination with 5-FU/LV and oxaliplatin (FOLFOX). (23rd October 2018) Authors: Hecht, J R; Naing, A; Falchook, G S; Patel, M R; Aljumaily, R; Wong, D J; Autio, K A; Wainberg, Z A; Javle, M; Bendell, J; Pant, S; Hung, A; Oft, M; Leveque, J; Papadopoulos, K P Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗